FDA accepts Pfizer’s blood cancer candidate for speedy review

FDA gave Pfizer a priority review to its experimental leukemia med inotuzumab ozogamicin. 

Novartis' Zykadia scores priority review and breakthrough designation from FDA

The FDA awarded Novartis’ lung cancer treatment Zykadia (ceritinib) both priority review and breakthrough therapy designation.

Afidro warned the Minister of Health in Colombia about the possible entry of drugs not tested in humans

Afidro requested the Minister of Health in Colombia to keep the regulation on biotechnologies to prevent the entry of drugs not tested on humans.